Oncolytics Biotech, Inc. (ONCY)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
-26.04% vs
Rating Accuracy
0% (0 of 1*)
FV Performance
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
9 Hits (20.93% Hit Rate)
FV Avg. Distance
+57.96%
*There is a current rating on the stock that is included in these numbers based on its performance so far
About
CEO
Matthew C. Coffey
Employees
23
Industry
-
Sector
-
Headquarters
Calgary
Exchange
NASDAQ
Website
http://www.oncolyticsbiotech.comSummary Stats
Market Cap
72.5M
Revenue
-
Net Income
-
EPS
$0.00
Price-to-Earnings
-
Price-to-Book
-
Debt-to-Equity
-
News
Analyst Ratings
Price targets projected by 4 analysts
High
$11.00
Average
$8.79
Low
$6.00
Ratings calculated by 3 analysts
Buy
3
Hold
0
Sell
0
Last Dividend
Amount
-
Dividend Date
-
Frequency
-
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q2 2022
Missed by $0.00
-$0.07 +-0.0%
-0.07
-0.11
Up 36%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--